Hedge Fund news.
Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk
Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy
Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
Loeb's Third Point LLC Hedge Fund Releases Q3 2011 13F
Loeb's Third Point Hedge Fund Gets Out of Citigroup (C), Shows New Stakes in CBS (CBS) and eBay (EBAY) Among Others
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA